Olympus to Distribute VisEn Near Infrared Fluorescence Probes and Fluorescence Tomographic Imaging Systems in Japan.Tokyo, Japan, Aug 11, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Olympus has announced an exclusive Japan distribution agreement covering VisEn's fluorescence molecular tomography (FMT FMT Format FMT Fremont (Fremont, California) FMT FSW (Flight Software) Maintenance Team FMT Flame Maple Top FMT Full Mission Trainer FMT Fissile Material Treaty FMT Filtered Multitone ) imaging systems and portfolio of in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body. in vi·vo adj. Within a living organism. in vivo adv. near infrared fluorescence probes. Olympus will commence sales of the products from September 1, 2006. By combining the VisEn products with the Olympus OV100 and IV100 molecular imaging systems, it will be possible to generate an unprecedented range of molecular imaging data in vivo, from the cellular and tissue levels to the quantification of molecular activities real time in the whole body. These products will accelerate progress in disease research and in drug development by significantly expanding molecular imaging applications and enhancing data quality in diseases including cancer, inflammation, cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease , and bone disease. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion